CONDENSED INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS COMPREHENSIVE (LOSS) INCOME AND DEFICIT (Unaudited) (CAD)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Revenues
Licensed domestic product net sales	2,242,333	2,267,509	6,378,621	6,104,160
Other domestic product sales	790,362	576,174	2,618,710	1,707,336
International product sales	347,551	369,816	1,037,103	1,193,219
Royalty and licensing revenues	99,884		197,924
Total revenues (Note 14)	3,480,130	3,213,499	10,232,358	9,004,715
Cost of Sales
Licensor sales and distribution fees	1,501,243	1,526,690	4,262,968	4,226,247
Cost of products sold	409,358	327,582	1,232,701	922,983
Total Cost of Sales	1,910,601	1,854,272	5,495,669	5,149,230
Gross profit	1,569,529	1,359,227	4,736,689	3,855,485
Expenses
Selling, general and administrative (Notes 12 and 15)	2,224,457	21,231,379	7,681,179	6,240,007
Amortization of assets (non-manufacturing property, plant and equipment)	313,635	155,807	977,693	380,270
Total operating expenses	2,538,092	2,287,186	8,658,872	6,620,277
(Loss) from operations	(968,563)	(927,959)	(3,922,183)	(2,764,792)
Non-operating income (expenses)
Change in warrant liability (Note 7c)	(660,325)	66,183	(1,510,800)	203,396
Cost of extending the warrant expiration				135,157
Change in fair value of contingent consideration				79,724
Research and development		(6,590)		(14,916)
Accretion expense	(20,895)	(45,826)	(68,123)	(100,193)
Loss on disposal of intangible asset (Note 5)	(161,200)		(1,261,200)
Loss on extinguishment of loan (Note 6)	(620,835)		(620,835)
Interest income	268	12,150	2,235	12,150
Interest expense	(152,026)	(103,551)	(320,029)	(158,175)
Loss and comprehensive loss before tax	(2,583,576)	(1,005,593)	(6,600,935)	(2,877,963)
Current income tax recovery		71,153		71,153
Deferred income tax recovery (Note 13)		215,800	314,900	730,440
Net loss and comprehensive loss for the period	(2,583,576)	(718,640)	(6,286,035)	(2,076,410)
Deficit, beginning of period	(11,426,015)	(5,732,360)	(7,723,556)	(4,374,590)
Deficit, end of period	(14,009,591)	(6,451,000)	(14,009,591)	(6,451,000)
Loss per share (Note 8) - Basic and diluted	(0.05)	(0.02)	(0.13)	(0.05)